and 87% retention after 50 cycles are achieved. This work provides an innovative interface engineering strategy for developing electrocatalysts that are resilient to poisoning.
Yang et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: